Australia markets close in 3 hours 38 minutes

Oncternal Therapeutics, Inc. (ONCT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
8.74+0.74 (+9.31%)
At close: 04:00PM EDT
8.01 -0.74 (-8.40%)
After hours: 06:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 24.42M
Enterprise value -9.52M
Trailing P/E 2.11
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.81
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.23

Trading information

Stock price history

Beta (5Y monthly) 1.37
52-week change 325.00%
S&P500 52-week change 321.33%
52-week high 313.20
52-week low 35.57
50-day moving average 38.83
200-day moving average 37.77

Share statistics

Avg vol (3-month) 37.73k
Avg vol (10-day) 32.97k
Shares outstanding 52.96M
Implied shares outstanding 62.96M
Float 82.68M
% held by insiders 19.23%
% held by institutions 115.24%
Shares short (15 Apr 2024) 413.8k
Short ratio (15 Apr 2024) 41.72
Short % of float (15 Apr 2024) 40.50%
Short % of shares outstanding (15 Apr 2024) 40.47%
Shares short (prior month 15 Mar 2024) 415k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 310 June 2019
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 308 Jan 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,244.44%

Management effectiveness

Return on assets (ttm)-49.48%
Return on equity (ttm)-86.75%

Income statement

Revenue (ttm)785k
Revenue per share (ttm)0.27
Quarterly revenue growth (yoy)73.70%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-39.48M
Diluted EPS (ttm)-13.43
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)34.26M
Total cash per share (mrq)11.57
Total debt (mrq)318k
Total debt/equity (mrq)1.06%
Current ratio (mrq)6.94
Book value per share (mrq)10.19

Cash flow statement

Operating cash flow (ttm)-32.16M
Levered free cash flow (ttm)-19.38M